WebMD Health Corp., an Internet Brands company and the leader in health information services for physicians and consumers, today announced that it has acquired prIME Oncology, a leading provider of independent medical education in oncology. The acquisition combines the depth and expertise of prIME Oncology with that of WebMD’s Medscape, the leading digital news, information, and education platform for physicians worldwide.
“We’re pleased to announce the strengthening of our commitment to continuing medical education with the acquisition of prIME Oncology, and we will continue our dedication to providing oncology practitioners timely and practical tools to improve patient outcomes,” said Rejean Rochette, Senior Vice President of Medscape Education. “The acquisition of prIME Oncology enhances our impact with oncologists while increasing our value to key stakeholders.”
“We couldn’t be more thrilled to be joining the oncology education team at WebMD,” said prIME Oncology President, Nathan Kelly. “This relationship will allow us to further our goal of delivering the medical education and clinical insights needed to improve care to patients with cancer.”
The acquisition expands the global footprint of the business, adding an office in The Hague to those in New York, Paris, and London. Medscape Oncology reaches more than 100,000 active hematology and oncology members worldwide and delivers education to professionals in 191 countries.* Atlanta-based prIME Oncology has a strong global presence with experience hosting live events on five continents.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Both businesses will continue to operate independently, as the companies build on and integrate products, platforms, and services.
Genesis Capital, LLC, acted as financial advisor to prIME Oncology, and King & Spalding LLP and NautaDutilh provided legal counsel. Terms of the deal are not being disclosed.
Date: October 15, 2018
Source: Cision
